Nurix Therapeutics, Inc. (NRIX)
15.48
-0.89
(-5.44%)
USD |
NASDAQ |
Jun 03, 16:00
15.48
0.00 (0.00%)
After-Hours: 07:37
Nurix Therapeutics Total Liabilities (Quarterly) : 155.24M for Feb. 28, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Ultragenyx Pharmaceutical, Inc. | 1.525B |
| Alpha Cognition, Inc. | 11.79M |
| ACADIA Pharmaceuticals, Inc. | 357.16M |
| Alnylam Pharmaceuticals, Inc. | 4.054B |
| Anika Therapeutics, Inc. | 45.49M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 636.13M |
| Shareholders Equity (Quarterly) | 480.89M |
| Debt to Equity Ratio | 0.122 |
| Current Ratio | 6.013 |
| Net Debt Paydown Yield | -0.37% |